HIGHLIGHTS
- who: Peter Bru00e6ndstrup from the Department of Haematology, Odense University Hospital, Denmark have published the Article: Concomitant Langerhans Cell Histiocytosis and Chronic Myelomonocytic Leukaemia Responding to 5-azacitidine, in the Journal: (JOURNAL)
SUMMARY
Langerhans cell histiocytosis (LCH) is a rare, clonal, haematological disease of myeloid origin involving infiltration of neoplastic cells resembling Langerhans cells in various tissues. LCH cells express normal Langerhans cell markers such as CD1a, Langerin (CD207), and S100. LCH predominates in children and common manifestations are in bones and skin, although any organ can be involved. In this classification LCH . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.